Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Nanning Xinzizhu to Distribute AOTI Wound Healing Device in China
MabPlex, a China Biologic CDMO, Closes $59 million Series A
Boehringer Ingelheim Expands Shanghai Biologics CDMO Facility
Cellular Biomedicine Approved to Start China Stem Cell Trial
Tyto Care Adds $9 Million to Series C for Telehealth Device/Services
Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China